Your browser does not support JavaScript!

Home    Αξιολόγηση κόστους και αποτελεσματικότητας εμφυτευμένων καρδιακών απινιδωτών και συσκευών αμφικοιλιακής βηματοδότησης  

Results - Details

Add to Basket
[Add to Basket]
Identifier 000378394
Title Αξιολόγηση κόστους και αποτελεσματικότητας εμφυτευμένων καρδιακών απινιδωτών και συσκευών αμφικοιλιακής βηματοδότησης
Alternative Title Cost effectiveness evaluation of implanted cardioverter defibrillators and biventricular therapy devices
Author Φανουργιάκης, Γιάννης
Thesis advisor Βάρδας, Παναγίωτης
Reviewer Υφαντόπουλος, Ιωάννης
Σημαντηράκης, Εμμανουήλ
Βελεγράκης, Γεώργιος
Λιονής, Χρήστος
Παρθενάκης, Φραγκίσκος
Χλουβεράκης, Γρηγόριος
Abstract Aims: The aim of the present study is to estimate the procedure (implantation) cost, the total hospitalization cost and annual follow up cost, in patients subjected to pacemaker (PM) and cardioverter-defibrillator (ICD) implantation. Methods: A single center, prospective, cost-of-illness study was conducted between August 2008 and July 2009. In total, 464 consecutive patients were recruited (370 were subjected to PM implantation and 94 to ICD implantation). Resource data were assessed at patients’ enrolment in the study and at 6th and 12th months of patients’ follow up. Then, the procedure cost, the total hospitalization cost as well as the annual patients’ follow up costs were calculated using a bottom up approach. Results: The mean (95 % CI) procedure cost of PM and ICD implantation (including the costs of devices, electrodes, other supplies and personnel’s time) was calculated to be €1,803 (€ 1,758–€ 1,858) and € 13,521 (€ 13,153–€ 13,892), respectively. The mean total hospitalization cost (including procedure cost, hospitalization cost, cost of laboratory and imaging diagnostic examinations and the indirect cost attributed to productivity lost due to patient’s hospitalization) was € 3,926 (€ 3,711–€ 4,167) for PM and € 17,764 (€ 16,852–€ 18,692) for ICD. The mean annual cost (direct and indirect) was € 1.816 (€ 1.433-€ 2.421) for PM and € 2.819 (€ 2.115-€ 3.703) for ICD. No difference was detected in the annual cost between patients with initial implantation and replacement. Conclusion: These data revealed that although these devices are associated with a relatively high upfront cost, the annual societal cost following the implantation is low. Therefore, implantation of such devices should be encouraged since these devices reduce the morbidity and mortality without a high economic burden to society.
Language Greek
Subject Cardiovascular system Equipment and supplies
Cost
Defibrillator
Economic evaluation
Follow up cost
Hospitalization cost
Pacemaker
Procedure cost
Απινιδωτής
Βηματοδότης
Κόστος
Κόστος διαδιακασίας
Κόστος παρακολούθησης
Νοσοκομειακό κόστος
Οικονομική αξιολόγηση
Συνολικό κόστος
Issue date 2013-04-16
Collection   School/Department--School of Medicine--Department of Medicine--Doctoral theses
  Type of Work--Doctoral theses
Views 259

Digital Documents
No preview available

Download document
View document
Views : 11